Abstract Submission Details

EXTENDED Deadline for Submission: 05.00 PM, THURSDAY 27 JUNE 2013

  • Abstracts should be submitted using the abstract template. Click here to download
  • Papers can only be presented by one presenter 
  • Abstract title should be in BLOCK CAPITALS 
  • Authors names should be on the next line 
  • In case of more than one author please underline the name of the presenting author 
  • Do not include degrees or titles  
  • Authors' organizations/institutions should appear on the next line and should include the suburb/city, state and country of the organizations/institutions.  

Abstract Body Format -
Must be 300 words or less, inclusive of title, author(s) names, and institutional affiliation(s) and references. Please do not use abbreviations unless defined in the abstract. All submissions should be in Microsoft Word format


Content should include the following sections:

Background and Aims: Include one or two sentences to introduce the broad topic area and provide a reason for the study. Provide a clear statement of the aims of the study. A hypothesis could be included in this section It may also be appropriate to add references to cited literature here. References will be included in the word limit. Authors are advised to keep references to a minimum, and to use an abbreviated referencing system, i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages.

Methods: In this section information on participants (and /or subjects) should be provided. This may include the number of participants, demographic information such as age and gender as well as the method of recruitment. (ie a random sample or a convenient sample). Study inclusion and exclusion criteria should be included in this section as well as a sample size calculation if presenting a randomised clinical trial. Measures and procedures used in the study are described in this section. Descriptions of analyses appear in the methods section.

Results: The purpose of the result section is to provide a description of the main findings of the study. Reference to potential results that were unavailable at the time that the abstract was submitted will not be acceptable. Submitted abstracts must include actual results. Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate. Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc).

Conclusions: In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature. It should not be a simple restatement of the results.


All abstracts will be reviewed by the abstract review committee within four weeks after the closing date.

All presenters must register for the conference by the Early Bird Deadline for registration (4 October 2013) or the presentation will be withdrawn from the program.


Themes to be considered

  • Intense pulsed light (IPL)
  • Photorejuvenation techniques
  • Fractioned laser technology
  • Dermal fillers for facial enhancement
  • Lasers for vascular / pigmented lesions
  • Use of botulinum toxin type A for facial rejuvenation
  • Laser theory
  • Diagnosis and management of skin cancer
  • Stems cells and anti-ageing medicine
  • Techniques for skin reconditioning
  • Non-surgical facial enhancement
  • Laser hair removal
  • Ultrasound liposuction
  • Medico-legal
  • Strategies to optimise your cosmetic practice

Contact us

For further information please contact the LCMC 2013 Secretariat:
DC Conferences Pty Ltd | Suite 103, Level 1, 3-5 West Street, North Sydney NSW 2060, Australia | PO Box 637, North Sydney 2059
P: 612 9954 4400 | F: 612 9954 0666 | E: lcmc2013@dccam.com.au

Another online solution from CocoNET